OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pyroptosis in Liver Disease: New Insights into Disease Mechanisms
Jiali Wu, Su Lin, Bo Wan, et al.
Aging and Disease (2019) Vol. 10, Iss. 5, pp. 1094-1094
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases
Carl Randall Harrell, Nemanja Jovičić, Valentin Djonov, et al.
Cells (2019) Vol. 8, Iss. 12, pp. 1605-1605
Open Access | Times Cited: 610

Cell Death in Liver Diseases: A Review
Layla Shojaie, Andrea Iorga, Lily Dara
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9682-9682
Open Access | Times Cited: 224

Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver
Erika Ramos‐Tovar, Pablo Muriel
Antioxidants (2020) Vol. 9, Iss. 12, pp. 1279-1279
Open Access | Times Cited: 224

Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages
Kasra Asgarpour, Zahra Shojaei, Fatemeh Amiri, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 154

The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
Lili Yu, Wei Hong, Shen Lu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 85

cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation
Jingwen Liu, Jing Zhou, Yuling Luan, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 30

pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation
Zhouxiang Liao, Lichao Yang, Xiaojing Cheng, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2

Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model
Isao Nagaoka, Hiroshi Tamura, Johannes Reich
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5973-5973
Open Access | Times Cited: 100

Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics
Carl Randall Harrell, Nemanja Jovičić, Valentin Djonov, et al.
Pharmaceutics (2020) Vol. 12, Iss. 5, pp. 474-474
Open Access | Times Cited: 98

Induction of Pyroptosis: A Promising Strategy for Cancer Treatment
Lei Wang, Xiaowei Qin, Jianmin Liang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 91

Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Arshi Khanam, Paul Saleeb, Shyam Kottilil
Cells (2021) Vol. 10, Iss. 5, pp. 1097-1097
Open Access | Times Cited: 85

Pathway network of pyroptosis and its potential inhibitors in acute kidney injury
Ning Li, Yuru Wang, Xinyue Wang, et al.
Pharmacological Research (2021) Vol. 175, pp. 106033-106033
Closed Access | Times Cited: 83

Peroxiredoxin 3 Inhibits Acetaminophen-Induced Liver Pyroptosis Through the Regulation of Mitochondrial ROS
Yue Wang, Yan Zhao, Zhecheng Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 68

The liver in sepsis: molecular mechanism of liver failure and their potential for clinical translation
Dustin Beyer, Jessica Hoff, Oliver Sommerfeld, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 55

Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer
Lei Li, Hailong Tian, Zhe Zhang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 15, Iss. 1, pp. 452-468
Closed Access | Times Cited: 51

Aflatoxin B1 Induces Inflammatory Liver Injury via Gut Microbiota in Mice
Lin Ye, Huodai Chen, Karl Wah Keung Tsim, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 28, pp. 10787-10797
Closed Access | Times Cited: 26

NLRP3 inflammasome in hepatic diseases: A pharmacological target
Erika Ramos‐Tovar, Pablo Muriel
Biochemical Pharmacology (2023) Vol. 217, pp. 115861-115861
Closed Access | Times Cited: 24

Mechanistic Differences in Cell Death Responses to Metal‐Based Engineered Nanomaterials in Kupffer Cells and Hepatocytes
Xiang Wang, Chong Hyun Chang, Jinhong Jiang, et al.
Small (2020) Vol. 16, Iss. 21
Open Access | Times Cited: 59

Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy
Jianan Zhao, Yiyang Hu, Jinghua Peng
Cellular & Molecular Biology Letters (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 48

Pyroptosis: A promising therapeutic target for noninfectious diseases
Tong Li, Guangjuan Zheng, Ben Li, et al.
Cell Proliferation (2021) Vol. 54, Iss. 11
Open Access | Times Cited: 44

Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy
Pengyu Yao, Yajuan Liu
Molecules (2022) Vol. 28, Iss. 1, pp. 272-272
Open Access | Times Cited: 37

Curcumin-loaded chitosan nanoparticles alleviate fenpropathrin-induced hepatotoxicity by regulating lipogenesis and pyroptosis in rats
Leena S. Alqahtani, Yasmina M. Abd‐Elhakim, Amany Abdel-Rahman Mohamed, et al.
Food and Chemical Toxicology (2023) Vol. 180, pp. 114036-114036
Closed Access | Times Cited: 17

Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles
Alejandra Hernández, Yana Geng, Rolando Sepúlveda, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 6, pp. 165753-165753
Open Access | Times Cited: 50

Page 1 - Next Page

Scroll to top